Matches in Nanopublications for { ?s ?p "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP109594.RAXE7BPiMrO9Xlv_pVms6ksG0dWI0V4grRlXCSZIO3TBQ130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109594.RAXE7BPiMrO9Xlv_pVms6ksG0dWI0V4grRlXCSZIO3TBQ130_provenance.
- NP107834.RAMIkQsYFOKAy40DWpKLU4bnPqcdukF3OidjVYu0_G-OU130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107834.RAMIkQsYFOKAy40DWpKLU4bnPqcdukF3OidjVYu0_G-OU130_provenance.
- NP171048.RATfZC0p39mgmEs1VMWFixpCqAHdPgiyGFr78tWZfs2sk130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171048.RATfZC0p39mgmEs1VMWFixpCqAHdPgiyGFr78tWZfs2sk130_provenance.
- NP108738.RA5YcT8MLwehyLWIK7jAbqJf5jK05uujR0e_Y4vTi7guc130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108738.RA5YcT8MLwehyLWIK7jAbqJf5jK05uujR0e_Y4vTi7guc130_provenance.
- NP207185.RAaRdblygpflmkc-Vp3-4PSjw-gZPdCTdkEkSmRRUITeo130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207185.RAaRdblygpflmkc-Vp3-4PSjw-gZPdCTdkEkSmRRUITeo130_provenance.
- NP171952.RABWKCoTcxfM5SQIdyU-Owo0akinVdHKHY9qUbM6vr6Xc130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171952.RABWKCoTcxfM5SQIdyU-Owo0akinVdHKHY9qUbM6vr6Xc130_provenance.
- NP207183.RAlgunQR7LIWQoIvRJ2I7vf8rB50imKRadwPnAXMNuHlI130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207183.RAlgunQR7LIWQoIvRJ2I7vf8rB50imKRadwPnAXMNuHlI130_provenance.
- NP207184.RAnSMhK7jJUK88AE9iNqOPkJlrzV8WD7A5-G3I7q-LAxg130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207184.RAnSMhK7jJUK88AE9iNqOPkJlrzV8WD7A5-G3I7q-LAxg130_provenance.
- NP207182.RAxpZQ2u0eA0Cl2dl40CKMg9OY96BSDvGCJyBTX3GiGrg130_assertion description "[Fibronectin and type IV collagen activate ERalpha AF-1 by the c-Src pathway in breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207182.RAxpZQ2u0eA0Cl2dl40CKMg9OY96BSDvGCJyBTX3GiGrg130_provenance.